ID   HROC43
AC   CVCL_1D20
DR   CLS; 300823
DR   Wikidata; Q54895295
RX   PubMed=25309914;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300823; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D21S11: 31.2
ST   D5S818: 11,12
ST   D7S820: 13
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UN ! B-LCL-HROC43
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 16
//
RX   PubMed=25309914; DOI=10.1155/2014/568693; PMCID=PMC4182691;
RA   Lange F., Franz B., Maletzki C., Linnebacher M., Huhns M., Jaster R.;
RT   "Biological and molecular effects of small molecule kinase inhibitors
RT   on low-passage human colorectal cancer cell lines.";
RL   BioMed Res. Int. 2014:568693.1-568693.13(2014).
//
RX   PubMed=31601052; DOI=10.3390/cancers11101520; PMCID=PMC6826890;
RA   Mullins C.S., Micheel B., Matschos S., Leuchter M., Burtin F.,
RA   Krohn M., Huhns M., Klar E., Prall F., Linnebacher M.;
RT   "Integrated biobanking and tumor model establishment of human
RT   colorectal carcinoma provides excellent tools for preclinical
RT   research.";
RL   Cancers (Basel) 11:1520.1-1520.18(2019).
//